Andere talen ChengDa Pharmaceuticals Co., Ltd.

Aandelen

301201

CNE100005766

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 17-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
20,63 ^CNY	-0,72%		-9,04%	-18,88%

21/04	ChengDa Pharmaceuticals Co, Ltd. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
09/01	ChengDa Pharmaceuticals Co, Ltd. (SZSE:301201) kondigt een aandeleninkoop aan voor CNY 60 miljoen aan aandelen.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

ChengDa Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	21/04
Tranche Update on ChengDa Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on January 9, 2024.	01/04
Certain A Shares of ChengDa Pharmaceuticals Co., Ltd. are subject to a Lock-Up Agreement Ending on 20-JAN-2024.	20/01
ChengDa Pharmaceuticals Co., Ltd. announces an Equity Buyback for CNY 60 million worth of its shares.	09/01
ChengDa Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.	09/01
ChengDa Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26-10-23
ChengDa Pharmaceuticals Co., Ltd.(XSEC:301201) added to S&P Global BMI Index	18-09-23
ChengDa Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	22-08-23
ChengDa Pharmaceuticals Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 7, 2023	03-07-23
Chengda Pharmaceuticals Co., Ltd. Announces Directorate Appointments	17-05-23
Chengda Pharmaceuticals Co., Ltd. Approves for the Year 2022	17-05-23
Chengda Pharmaceuticals Co., Ltd. Proposes Final Cash Dividend for 2022	24-04-23
ChengDa Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-23
Certain A Shares of ChengDa Pharmaceuticals Co., Ltd. are subject to a Lock-Up Agreement Ending on 20-JAN-2023.	20-01-23
One Gene announced that it has received funding from ChengDa Pharmaceuticals Co., Ltd.	08-12-22
Hangzhou 1gene Technology Co., Ltd. announced that it has received CNY 19.48156 million in funding from ChengDa Pharmaceuticals Co., Ltd.	08-12-22
Hangzhou 1gene Technology Co., Ltd. announced that it expects to receive CNY 30 million in funding from ChengDa Pharmaceuticals Co., Ltd.	07-11-22
ChengDa Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25-10-22
ChengDa Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	14-08-22
ChengDa Pharmaceuticals to Free Up 1.29% Stake For Trading	18-07-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ChengDa Pharmaceuticals Co., Ltd.

Aandelen

301201

CNE100005766

Andere talen

Filters